Evaluation of the Completeness and Timeliness of the Infant Pertussis Surveillance System in the Czech Republic in 2015, 2017 and 2019
暂无分享,去创建一个
[1] M. Valenciano,et al. Effectiveness of pertussis vaccination in pregnancy to prevent hospitalisation in infants aged <2 months and effectiveness of both primary vaccination and mother's vaccination in pregnancy in infants aged 2-11 months , 2022, Vaccine.
[2] C. Rizzo,et al. The impact of pertussis in infants: insights from a hospital-based enhanced surveillance system, Lazio region, Italy, 2016 to 2019 , 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[3] M. Valenciano,et al. Incidence and severity of pertussis hospitalisations in infants aged less than 1 year in 37 hospitals of six EU/EEA countries, results of PERTINENT sentinel pilot surveillance system, December 2015 to December 2018. , 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[4] A. Mattei,et al. Pertussis in Italy: how to protect the “unprotectable”? , 2020, Human vaccines & immunotherapeutics.
[5] A. Guignard,et al. A systematic review of the burden of pertussis disease in infants and the effectiveness of maternal immunization against pertussis , 2020, Expert review of vaccines.
[6] A. Nitsch-Osuch,et al. Comparative Epidemiologic Characteristics of Pertussis in 10 Central and Eastern European Countries, 2000-2013 , 2016, PloS one.
[7] P. Krizova,et al. The Czech Surveillance System for Invasive Pneumococcal Disease, 2008-2013: A Follow-Up Assessment and Sensitivity Estimation , 2015, PloS one.
[8] L. Nilsson,et al. Surveillance of infant pertussis in Sweden 1998-2012; severity of disease in relation to the national vaccination programme. , 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[9] B. Kříž,et al. [Pertussis trend in children under one year of age in the Czech Republic in 1997-2013]. , 2014, Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne.
[10] M. Rosińska,et al. Cross-border surveillance differences: tick-borne encephalitis and lyme borreliosis in the Czech Republic and Poland, 1999-2008. , 2014, Central European journal of public health.
[11] Jim E van Steenbergen,et al. Analysis of timeliness of infectious disease reporting in the Netherlands , 2011, BMC public health.
[12] J. Kovář,et al. CYP7A1 promoter polymorphism −203A>C affects bile salt synthesis rate in patients after ileal resection Published, JLR Papers in Press, August 26, 2008. This work was supported by Grant NR 8963-3 from the Ministry of Health of the Czech Republic. , 2008, Journal of Lipid Research.
[13] P. Kriz. Surveillance of invasive meningococcal disease in the Czech Republic. , 2004, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[14] J. Kynčl,et al. What risk factors affect hospitalisation for confirmed pertussis cases among infants in the Czech Republic? , 2022, Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne.
[15] R. Evans. European Centre for Disease Prevention and Control. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[16] Shane Marley,et al. Control of Communicable Diseases Manual , 1997, Annals of Internal Medicine.
[17] S. Miller,et al. Control of communicable diseases. , 1949, The Journal-lancet.